Literature DB >> 11940651

P53 is necessary for the apoptotic response mediated by a transient increase of Ras activity.

Peihong Ma1, Maureen Magut, XinBin Chen, Chang-Yan Chen.   

Abstract

The tumor suppressor p53 eliminates cancer-prone cells via multiple mechanisms, including apoptosis. Ras elicits apoptosis in cells after protein kinase C (PKC) downregulation. However, the role of p53 in Ras-mediated apoptosis has not been fully investigated. Here, we demonstrate that mouse fibroblasts that express wild-type p53 are more susceptible to apoptosis elicited by PKC inhibition if Ras is transiently expressed or upregulated as opposed to stably expressed. In the latter case, p53 is frequently mutated. Transiently increased Ras activity induces Bax, and PKC inhibition augments this induction. Overexpression of E6 inactivates p53 and thereby suppresses both Bax induction and apoptosis. In contrast, Bax is not induced in stable ras transfectants, regardless of PKC inhibition. The data suggest that short- and long-term activation of Ras use a different mechanism(s) to initiate apoptosis. The status of p53 may contribute to such differences.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940651      PMCID: PMC133752          DOI: 10.1128/MCB.22.9.2928-2938.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

Review 1.  p53: death star.

Authors:  K H Vousden
Journal:  Cell       Date:  2000-11-22       Impact factor: 41.582

2.  The ins and outs of p53.

Authors:  K H Vousden; G F Vande Woude
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

Review 3.  p53 function and dysfunction.

Authors:  B Vogelstein; K W Kinzler
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

4.  Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.

Authors:  L Johnson; K Mercer; D Greenbaum; R T Bronson; D Crowley; D A Tuveson; T Jacks
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

5.  Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

Authors:  P Shaw; R Bovey; S Tardy; R Sahli; B Sordat; J Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

6.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

Authors:  Z N Oltvai; C L Milliman; S J Korsmeyer
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

Review 7.  Function and regulation of ras.

Authors:  D R Lowy; B M Willumsen
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

8.  Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation.

Authors:  X Lu; S H Park; T C Thompson; D P Lane
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

9.  Altered growth of human colon cancer cell lines disrupted at activated Ki-ras.

Authors:  S Shirasawa; M Furuse; N Yokoyama; T Sasazuki
Journal:  Science       Date:  1993-04-02       Impact factor: 47.728

Review 10.  Transgenic models of tumor development.

Authors:  J M Adams; S Cory
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

View more
  5 in total

1.  Involvement of Rho family GTPases in p19Arf- and p53-mediated proliferation of primary mouse embryonic fibroblasts.

Authors:  Fukun Guo; Yi Zheng
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

2.  Protein kinase Cδ inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors.

Authors:  Zhihong Chen; Lora W Forman; Kenneth A Miller; Brandon English; Asami Takashima; Regine A Bohacek; Robert M Williams; Douglas V Faller
Journal:  Endocr Relat Cancer       Date:  2011-12-01       Impact factor: 5.678

3.  PI3K Acts in synergy with loss of PKC to elicit apoptosis via the UPR.

Authors:  Jinjin Guo; Tongbo Zhu; Ling-Yu Luo; Yi Huang; Raja G Sunkavalli; Chang Yan Chen
Journal:  J Cell Biochem       Date:  2009-05-01       Impact factor: 4.429

4.  Targeting Bcl-2 stability to sensitize cells harboring oncogenic ras.

Authors:  Bo Peng; Suthakar Ganapathy; Ling Shen; Junchi Huang; Bo Yi; Xiaodong Zhou; Wei Dai; Changyan Chen
Journal:  Oncotarget       Date:  2015-09-08

5.  Ral A, via activating the mitotic checkpoint, sensitizes cells lacking a functional Nf1 to apoptosis in the absence of protein kinase C.

Authors:  Suthakar Ganapathy; Johan B Fagman; Ling Shen; Tianqi Yu; Xiaodong Zhou; Wei Dai; Alexandros Makriyannis; Changyan Chen
Journal:  Oncotarget       Date:  2016-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.